CTE.AX Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 jul 2024 @ 06:33):
Our systems believe the stock currently is overvalued by -0.07% compare to its pairs and should correct downwards.

Stats
Dagens volum	17 196
Gjennomsnittsvolum	25 753
Markedsverdi	61.01M
EPS	$0.0173 ( Q2 \| 2023-12-31 )
Neste inntjeningsdato	( $0 ) 2024-08-21
Last Dividend	$0.0500 ( 2024-02-21 )
Next Dividend	$0 ( N/A )
P/E	41.67 (Sector) 0 (Industry) 0
ATR14	$0 (0.00%)

ACW.AX 4.84%

ADO.AX 5.00%

AGH.AX 4.35%

ANP.AX -4.92%

ATH.AX 25.00%

AVE.AX -33.33%

BIT.AX 2.63%

BNO.AX -10.00%

BOT.AX -8.70%

CAN.AX 7.14%

CPH.AX 0.00%

CSL.AX -0.88%

CTE.AX 0.81%

CUV.AX -0.65%

CYP.AX 0.00%

DXB.AX 3.92%

ECS.AX 5.88%

EOF.AX -6.67%

GSS.AX 5.56%

IDT.AX -4.55%

IMC.AX -5.68%

IMM.AX 5.08%

IMU.AX -3.51%

IXC.AX 0.00%

KZA.AX 9.59%

LCT.AX 7.14%

LGP.AX 5.26%

MSB.AX 1.01%

MVP.AX -2.47%

MXC.AX 2.44%

NEU.AX -4.98%

NOX.AX 0.00%

NSB.AX 0.00%

OCC.AX 2.82%

OPT.AX -1.43%

OSL.AX 25.00%

PAA.AX 0.00%

PAB.AX 14.29%

PAR.AX 13.73%

PBP.AX 0.00%

PIQ.AX -1.14%

PTX.AX 5.26%

PXS.AX 3.70%

PYC.AX 0.00%

RAC.AX -0.27%

RCE.AX 5.26%

SPL.AX -3.16%

TLX.AX -3.00%

VBS.AX -1.30%

Korrelasjon (AI algo v.1.1b): Overvalued: -0.07% $1.251 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Cryosite Ltd Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Cryosite Ltd Økonomi

Annual	2023
Omsetning:	$11.94M
Bruttogevinst:	$6.48M (54.28 %)
EPS:	$0.0289

FY	2023
Omsetning:	$11.94M
Bruttogevinst:	$6.48M (54.28 %)
EPS:	$0.0289

FY	2022
Omsetning:	$11.76M
Bruttogevinst:	$6.27M (53.36 %)
EPS:	$0.0279

FY	2021
Omsetning:	$10.02M
Bruttogevinst:	$5.89M (58.80 %)
EPS:	$0.0139

Financial Reports:

No articles found.

Cryosite Ltd Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.0100 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0.0150 (N/A)	$0 (N/A)	$0.0500 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Cryosite Ltd Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 7.20 - Increase likely (43.98%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.00500	2012-03-16
Last Dividend	$0.0500	2024-02-21
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	14	--
Total Paid Out	$0.140	--
Avg. Dividend % Per Year	3.74%	--
Score	4.9	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	7.20
Div. Directional Score	9.22	--

Next Divdend (Est)
(2024-09-24)

$0.0611 Estimate 11.30 %

Dividend Stability

0.45 Below Average

Dividend Score

4.90

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2012	$0.0100	6.90%
2013	$0.0150	3.95%
2014	$0.0150	3.26%
2015	$0.0100	2.56%
2016	$0.0100	4.26%
2017	$0.00500	2.86%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0.0100	2.17%
2023	$0.0150	2.08%
2024	$0.0500	8.26%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
21 Feb 2024	$0.0500	30 Nov -0001	30 Nov -0001	30 Nov -0001
07 Sep 2023	$0.0150	30 Nov -0001	08 Sep 2023	06 Oct 2023
15 Sep 2022	$0.0100	30 Nov -0001	16 Sep 2022	14 Oct 2022
14 Mar 2017	$0.00500	22 Feb 2017	15 Mar 2017	31 Mar 2017
07 Sep 2016	$0.00500	24 Aug 2016	08 Sep 2016	04 Oct 2016
11 Mar 2016	$0.00500	24 Feb 2016	15 Mar 2016	31 Mar 2016
08 Sep 2015	$0.00500	26 Aug 2015	10 Sep 2015	01 Oct 2015
13 Mar 2015	$0.00500	25 Feb 2015	17 Mar 2015	31 Mar 2015
08 Sep 2014	$0.0100	28 Aug 2014	10 Sep 2014	24 Sep 2014
17 Mar 2014	$0.00500	26 Feb 2014	21 Mar 2014	04 Apr 2014
23 Sep 2013	$0.0100	29 Aug 2013	27 Sep 2013	23 Oct 2013
18 Mar 2013	$0.00500	26 Feb 2013	22 Mar 2013	05 Apr 2013
28 Sep 2012	$0.00500	23 Aug 2012	05 Oct 2012	23 Oct 2012
16 Mar 2012	$0.00500	28 Feb 2012	22 Mar 2012	05 Apr 2012

Top 10 dividend Companies for ASX

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
EZL.AX	Dividend Royal	2024-02-02	Semi-Annually	24	11.64%	8.24
GRR.AX	Dividend Royal	2024-03-12	Semi-Annually	14	11.88%	7.99
RKN.AX	Dividend Royal	2023-08-31	Annually	22	15.73%	7.24
TWR.AX	Dividend King	2024-06-12	Annually	25	5.98%	7.21
YAL.AX	Dividend Royal	2024-03-12	Annually	7	12.76%	7.18
SHM.AX	Dividend Royal	2024-03-14	Semi-Annually	9	14.97%	7.14
HZN.AX	Dividend Royal	2024-04-18	Semi-Annually	4	18.99%	7.06
BHP.AX	Dividend Royal	2024-03-07	Semi-Annually	37	6.46%	6.97
CDD.AX	Ex Dividend King	2024-05-24	Annually	21	91.43%	6.79
KSL.AX	Dividend Royal	2024-03-05	Semi-Annually	9	9.58%	6.77

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.125	1.500	7.50	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0711	1.200	7.63	9.16	[0 - 0.3]
returnOnEquityTTM	0.555	1.500	4.94	7.41	[0.1 - 1]
payoutRatioTTM	0.464	-1.000	5.36	-5.36	[0 - 1]
currentRatioTTM	2.03	0.800	4.85	3.88	[1 - 3]
quickRatioTTM	1.942	0.800	3.28	2.63	[0.8 - 2.5]
cashRatioTTM	1.458	1.500	3.01	4.51	[0.2 - 2]
debtRatioTTM	0.114	-1.500	8.10	-10.00	[0 - 0.6]
interestCoverageTTM	15.39	1.000	5.41	5.41	[3 - 30]
operatingCashFlowPerShareTTM	0.0493	2.00	9.98	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0405	2.00	9.98	10.00	[0 - 20]
debtEquityRatioTTM	0.873	-1.500	6.51	-9.76	[0 - 2.5]
grossProfitMarginTTM	0.550	1.000	4.17	4.17	[0.2 - 0.8]
operatingProfitMarginTTM	0.138	1.000	9.23	9.23	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.952	1.000	5.82	5.82	[0.2 - 2]
assetTurnoverTTM	0.569	0.800	9.54	7.63	[0.5 - 2]
Total Score				11.25

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	38.40	1.000	6.22	0	[1 - 100]
returnOnEquityTTM	0.555	2.50	6.75	7.41	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0405	2.00	9.99	10.00	[0 - 30]
dividendYielPercentageTTM	5.24	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.0493	2.00	9.98	10.00	[0 - 30]
payoutRatioTTM	0.464	1.500	5.36	-5.36	[0 - 1]
pegRatioTTM	3.50	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.191	1.000	7.73	0	[0.1 - 0.5]
Total Score				7.20

Cryosite Ltd Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Cryosite Ltd

Cryosite Limited offers outsourced clinical trials logistic services in Australia. It operates through two segments, Clinical Trials and Biological Services Logistics, and Cord Blood and Tissues Storage. The Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns management, comparator sourcing, import, export, validated transport, and biological storage solutions to the clinical trials, and research and pharmaceutical industry. The Cord Blood and Tissues Storage segment offers long term storage solutions for cord blood and tissue samples. It serves research, medical, pharmaceutical, veterinary, and biotechnology industries. The company was incorporated in 1999 and is based in South Granville, Australia.